Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 59

1.

Heart Failure in the Era of Precision Medicine: A Scientific Statement From the American Heart Association.

Cresci S, Pereira NL, Ahmad F, Byku M, de Las Fuentes L, Lanfear DE, Reilly CM, Owens AT, Wolf MJ; American Heart Association Council on Genomic and Precision Medicine; Council on Cardiovascular and Stroke Nursing; and Council on Quality of Care and Outcomes Research.

Circ Genom Precis Med. 2019 Sep 12:HCG0000000000000058. doi: 10.1161/HCG.0000000000000058. [Epub ahead of print]

PMID:
31510778
2.

A Genetic Locus on Chromosome 2q24 Predicting Peripheral Neuropathy Risk in Type 2 Diabetes: Results From the ACCORD and BARI 2D Studies.

Tang Y, Lenzini PA, Pop-Busui R, Ray PR, Campbell H, Perkins BA, Callaghan B, Wagner MJ, Motsinger-Reif AA, Buse JB, Price TJ, Mychaleckyj JC, Cresci S, Shah H, Doria A.

Diabetes. 2019 Aug;68(8):1649-1662. doi: 10.2337/db19-0109. Epub 2019 May 24.

PMID:
31127053
3.

Association of Chromosome 9p21 With Subsequent Coronary Heart Disease Events.

Patel RS, Schmidt AF, Tragante V, McCubrey RO, Holmes MV, Howe LJ, Direk K, Åkerblom A, Leander K, Virani SS, Kaminski KA, Muehlschlegel JD, Dubé MP, Allayee H, Almgren P, Alver M, Baranova EV, Behlouli H, Boeckx B, Braund PS, Breitling LP, Delgado G, Duarte NE, Dufresne L, Eriksson N, Foco L, Gijsberts CM, Gong Y, Hartiala J, Heydarpour M, Hubacek JA, Kleber M, Kofink D, Kuukasjärvi P, Lee VV, Leiherer A, Lenzini PA, Levin D, Lyytikäinen LP, Martinelli N, Mons U, Nelson CP, Nikus K, Pilbrow AP, Ploski R, Sun YV, Tanck MWT, Tang WHW, Trompet S, van der Laan SW, van Setten J, Vilmundarson RO, Viviani Anselmi C, Vlachopoulou E, Boerwinkle E, Briguori C, Carlquist JF, Carruthers KF, Casu G, Deanfield J, Deloukas P, Dudbridge F, Fitzpatrick N, Gigante B, James S, Lokki ML, Lotufo PA, Marziliano N, Mordi IR, Muhlestein JB, Newton Cheh C, Pitha J, Saely CH, Samman-Tahhan A, Sandesara PB, Teren A, Timmis A, Van de Werf F, Wauters E, Wilde AAM, Ford I, Stott DJ, Algra A, Andreassi MG, Ardissino D, Arsenault BJ, Ballantyne CM, Bergmeijer TO, Bezzina CR, Body SC, Bogaty P, de Borst GJ, Brenner H, Burkhardt R, Carpeggiani C, Condorelli G, Cooper-DeHoff RM, Cresci S, de Faire U, Doughty RN, Drexel H, Engert JC, Fox KAA, Girelli D, Hagström E, Hazen SL, Held C, Hemingway H, Hoefer IE, Hovingh GK, Johnson JA, de Jong PA, Jukema JW, Kaczor MP, Kähönen M, Kettner J, Kiliszek M, Klungel OH, Lagerqvist B, Lambrechts D, Laurikka JO, Lehtimäki T, Lindholm D, Mahmoodi BK, Maitland-van der Zee AH, McPherson R, Melander O, Metspalu A, Pepinski W, Olivieri O, Opolski G, Palmer CN, Pasterkamp G, Pepine CJ, Pereira AC, Pilote L, Quyyumi AA, Richards AM, Sanak M, Scholz M, Siegbahn A, Sinisalo J, Smith JG, Spertus JA, Stewart AFR, Szczeklik W, Szpakowicz A, Ten Berg JM, Thanassoulis G, Thiery J, van der Graaf Y, Visseren FLJ, Waltenberger J; CARDIoGRAMPlusC4D Consortium, Van der Harst P, Tardif JC, Sattar N, Lang CC, Pare G, Brophy JM, Anderson JL, März W, Wallentin L, Cameron VA, Horne BD, Samani NJ, Hingorani AD, Asselbergs FW.

Circ Genom Precis Med. 2019 Apr;12(4):e002471. doi: 10.1161/CIRCGEN.119.002471. Epub 2019 Mar 21.

PMID:
30897348
4.

Subsequent Event Risk in Individuals With Established Coronary Heart Disease.

Patel RS, Tragante V, Schmidt AF, McCubrey RO, Holmes MV, Howe LJ, Direk K, Åkerblom A, Leander K, Virani SS, Kaminski KA, Muehlschlegel JD, Allayee H, Almgren P, Alver M, Baranova EV, Behloui H, Boeckx B, Braund PS, Breitling LP, Delgado G, Duarte NE, Dubé MP, Dufresne L, Eriksson N, Foco L, Scholz M, Gijsberts CM, Glinge C, Gong Y, Hartiala J, Heydarpour M, Hubacek JA, Kleber M, Kofink D, Kotti S, Kuukasjärvi P, Lee VV, Leiherer A, Lenzini PA, Levin D, Lyytikäinen LP, Martinelli N, Mons U, Nelson CP, Nikus K, Pilbrow AP, Ploski R, Sun YV, Tanck MWT, Tang WHW, Trompet S, van der Laan SW, Van Setten J, Vilmundarson RO, Viviani Anselmi C, Vlachopoulou E, Al Ali L, Boerwinkle E, Briguori C, Carlquist JF, Carruthers KF, Casu G, Deanfield J, Deloukas P, Dudbridge F, Engstrøm T, Fitzpatrick N, Fox K, Gigante B, James S, Lokki ML, Lotufo PA, Marziliano N, Mordi IR, Muhlestein JB, Newton-Cheh C, Pitha J, Saely CH, Samman-Tahhan A, Sandesara PB, Teren A, Timmis A, Van de Werf F, Wauters E, Wilde AAM, Ford I, Stott DJ, Algra A, Andreassi MG, Ardissino D, Arsenault BJ, Ballantyne CM, Bergmeijer TO, Bezzina CR, Body SC, Boersma EH, Bogaty P, Bots ML, Brenner H, Brugts JJ, Burkhardt R, Carpeggiani C, Condorelli G, Cooper-DeHoff RM, Cresci S, Danchin N, de Faire U, Doughty RN, Drexel H, Engert JC, Fox KAA, Girelli D, Grobbee DE, Hagström E, Hazen SL, Held C, Hemingway H, Hoefer IE, Hovingh GK, Jabbari R, Johnson JA, Jukema JW, Kaczor MP, Kähönen M, Kettner J, Kiliszek M, Klungel OH, Lagerqvist B, Lambrechts D, Laurikka JO, Lehtimäki T, Lindholm D, Mahmoodi BK, Maitland-van der Zee AH, McPherson R, Melander O, Metspalu A, Niemcunowicz-Janica A, Olivieri O, Opolski G, Palmer CN, Pasterkamp G, Pepine CJ, Pereira AC, Pilote L, Quyyumi AA, Richards AM, Sanak M, Siegbahn A, Simon T, Sinisalo J, Smith JG, Spertus JA, Stender S, Stewart AFR, Szczeklik W, Szpakowicz A, Tardif JC, Ten Berg JM, Tfelt-Hansen J, Thanassoulis G, Thiery J, Torp-Pedersen C, van der Graaf Y, Visseren FLJ, Waltenberger J, Weeke PE, Van der Harst P, Lang CC, Sattar N, Cameron VA, Anderson JL, Brophy JM, Pare G, Horne BD, März W, Wallentin L, Samani NJ, Hingorani AD, Asselbergs FW.

Circ Genom Precis Med. 2019 Apr;12(4):e002470. doi: 10.1161/CIRCGEN.119.002470. Epub 2019 Mar 21.

PMID:
30896328
5.

A novel genetic marker of decreased inflammation and improved survival after acute myocardial infarction.

Coverstone ED, Bach RG, Chen L, Bierut LJ, Li AY, Lenzini PA, O'Neill HC, Spertus JA, Sucharov CC, Stitzel JA, Schilling JD, Cresci S.

Basic Res Cardiol. 2018 Aug 10;113(5):38. doi: 10.1007/s00395-018-0697-7.

6.

Association between the EPHX2 p.Lys55Arg polymorphism and prognosis following an acute coronary syndrome.

Oni-Orisan A, Cresci S, Jones PG, Theken KN, Spertus JA, Lee CR.

Prostaglandins Other Lipid Mediat. 2018 Sep;138:15-22. doi: 10.1016/j.prostaglandins.2018.07.005. Epub 2018 Aug 7.

7.

Smoking Interacts With CHRNA5, a Nicotinic Acetylcholine Receptor Subunit Gene, to Influence the Risk of IBD-Related Surgery.

Cushing KC, Chiplunker A, Li A, Sung YJ, Geisman T, Chen LS, Cresci S, Gutierrez AM.

Inflamm Bowel Dis. 2018 Apr 23;24(5):1057-1064. doi: 10.1093/ibd/izx094.

8.

Slow Gait Speed and Cardiac Rehabilitation Participation in Older Adults After Acute Myocardial Infarction.

Flint K, Kennedy K, Arnold SV, Dodson JA, Cresci S, Alexander KP.

J Am Heart Assoc. 2018 Feb 24;7(5). pii: e008296. doi: 10.1161/JAHA.117.008296.

9.

Relations between lipoprotein(a) concentrations, LPA genetic variants, and the risk of mortality in patients with established coronary heart disease: a molecular and genetic association study.

Zewinger S, Kleber ME, Tragante V, McCubrey RO, Schmidt AF, Direk K, Laufs U, Werner C, Koenig W, Rothenbacher D, Mons U, Breitling LP, Brenner H, Jennings RT, Petrakis I, Triem S, Klug M, Filips A, Blankenberg S, Waldeyer C, Sinning C, Schnabel RB, Lackner KJ, Vlachopoulou E, Nygård O, Svingen GFT, Pedersen ER, Tell GS, Sinisalo J, Nieminen MS, Laaksonen R, Trompet S, Smit RAJ, Sattar N, Jukema JW, Groesdonk HV, Delgado G, Stojakovic T, Pilbrow AP, Cameron VA, Richards AM, Doughty RN, Gong Y, Cooper-DeHoff R, Johnson J, Scholz M, Beutner F, Thiery J, Smith JG, Vilmundarson RO, McPherson R, Stewart AFR, Cresci S, Lenzini PA, Spertus JA, Olivieri O, Girelli D, Martinelli NI, Leiherer A, Saely CH, Drexel H, Mündlein A, Braund PS, Nelson CP, Samani NJ, Kofink D, Hoefer IE, Pasterkamp G, Quyyumi AA, Ko YA, Hartiala JA, Allayee H, Tang WHW, Hazen SL, Eriksson N, Held C, Hagström E, Wallentin L, Åkerblom A, Siegbahn A, Karp I, Labos C, Pilote L, Engert JC, Brophy JM, Thanassoulis G, Bogaty P, Szczeklik W, Kaczor M, Sanak M, Virani SS, Ballantyne CM, Lee VV, Boerwinkle E, Holmes MV, Horne BD, Hingorani A, Asselbergs FW, Patel RS; GENIUS-CHD consortium, Krämer BK, Scharnagl H, Fliser D, März W, Speer T.

Lancet Diabetes Endocrinol. 2017 Jul;5(7):534-543. doi: 10.1016/S2213-8587(17)30096-7. Epub 2017 May 26.

11.

A framework for detecting unfolding emergencies using humans as sensors.

Avvenuti M, Cimino MG, Cresci S, Marchetti A, Tesconi M.

Springerplus. 2016 Jan 19;5:43. doi: 10.1186/s40064-016-1674-y. eCollection 2016.

12.

Association of Smoking Status With Angina and Health-Related Quality of Life After Acute Myocardial Infarction.

Buchanan DM, Arnold SV, Gosch KL, Jones PG, Longmore LS, Spertus JA, Cresci S.

Circ Cardiovasc Qual Outcomes. 2015 Sep;8(5):493-500.

13.

Utility of a genetic risk score to predict recurrent cardiovascular events 1 year after an acute coronary syndrome: A pooled analysis of the RISCA, PRAXY, and TRIUMPH cohorts.

Labos C, Martinez SC, Leo Wang RH, Lenzini PA, Pilote L, Bogaty P, Brophy JM, Engert JC, Cresci S, Thanassoulis G.

Atherosclerosis. 2015 Sep;242(1):261-7. doi: 10.1016/j.atherosclerosis.2015.07.029. Epub 2015 Jul 17.

14.

CYP450 pharmacogenomics: a cardiology perspective.

Depta JP, Cresci S.

Per Med. 2015 Mar;12(2):59-62. doi: 10.2217/pme.14.76. No abstract available.

PMID:
29754539
15.

Exome sequencing identifies rare LDLR and APOA5 alleles conferring risk for myocardial infarction.

Do R, Stitziel NO, Won HH, Jørgensen AB, Duga S, Angelica Merlini P, Kiezun A, Farrall M, Goel A, Zuk O, Guella I, Asselta R, Lange LA, Peloso GM, Auer PL; NHLBI Exome Sequencing Project, Girelli D, Martinelli N, Farlow DN, DePristo MA, Roberts R, Stewart AF, Saleheen D, Danesh J, Epstein SE, Sivapalaratnam S, Hovingh GK, Kastelein JJ, Samani NJ, Schunkert H, Erdmann J, Shah SH, Kraus WE, Davies R, Nikpay M, Johansen CT, Wang J, Hegele RA, Hechter E, Marz W, Kleber ME, Huang J, Johnson AD, Li M, Burke GL, Gross M, Liu Y, Assimes TL, Heiss G, Lange EM, Folsom AR, Taylor HA, Olivieri O, Hamsten A, Clarke R, Reilly DF, Yin W, Rivas MA, Donnelly P, Rossouw JE, Psaty BM, Herrington DM, Wilson JG, Rich SS, Bamshad MJ, Tracy RP, Cupples LA, Rader DJ, Reilly MP, Spertus JA, Cresci S, Hartiala J, Tang WH, Hazen SL, Allayee H, Reiner AP, Carlson CS, Kooperberg C, Jackson RD, Boerwinkle E, Lander ES, Schwartz SM, Siscovick DS, McPherson R, Tybjaerg-Hansen A, Abecasis GR, Watkins H, Nickerson DA, Ardissino D, Sunyaev SR, O'Donnell CJ, Altshuler D, Gabriel S, Kathiresan S.

Nature. 2015 Feb 5;518(7537):102-6. doi: 10.1038/nature13917. Epub 2014 Dec 10.

16.

Inactivating mutations in NPC1L1 and protection from coronary heart disease.

Myocardial Infarction Genetics Consortium Investigators, Stitziel NO, Won HH, Morrison AC, Peloso GM, Do R, Lange LA, Fontanillas P, Gupta N, Duga S, Goel A, Farrall M, Saleheen D, Ferrario P, König I, Asselta R, Merlini PA, Marziliano N, Notarangelo MF, Schick U, Auer P, Assimes TL, Reilly M, Wilensky R, Rader DJ, Hovingh GK, Meitinger T, Kessler T, Kastrati A, Laugwitz KL, Siscovick D, Rotter JI, Hazen SL, Tracy R, Cresci S, Spertus J, Jackson R, Schwartz SM, Natarajan P, Crosby J, Muzny D, Ballantyne C, Rich SS, O'Donnell CJ, Abecasis G, Sunaev S, Nickerson DA, Buring JE, Ridker PM, Chasman DI, Austin E, Kullo IJ, Weeke PE, Shaffer CM, Bastarache LA, Denny JC, Roden DM, Palmer C, Deloukas P, Lin DY, Tang ZZ, Erdmann J, Schunkert H, Danesh J, Marrugat J, Elosua R, Ardissino D, McPherson R, Watkins H, Reiner AP, Wilson JG, Altshuler D, Gibbs RA, Lander ES, Boerwinkle E, Gabriel S, Kathiresan S.

N Engl J Med. 2014 Nov 27;371(22):2072-82. doi: 10.1056/NEJMoa1405386. Epub 2014 Nov 12.

17.

Clinical outcomes associated with proton pump inhibitor use among clopidogrel-treated patients within CYP2C19 genotype groups following acute myocardial infarction.

Depta JP, Lenzini PA, Lanfear DE, Wang TY, Spertus JA, Bach RG, Cresci S.

Pharmacogenomics J. 2015 Feb;15(1):20-5. doi: 10.1038/tpj.2014.28. Epub 2014 Jul 8.

18.

Cytochrome p450 gene variants, race, and mortality among clopidogrel-treated patients after acute myocardial infarction.

Cresci S, Depta JP, Lenzini PA, Li AY, Lanfear DE, Province MA, Spertus JA, Bach RG.

Circ Cardiovasc Genet. 2014 Jun;7(3):277-86. doi: 10.1161/CIRCGENETICS.113.000303. Epub 2014 Apr 24.

19.

Association between diabetes mellitus and angina after acute myocardial infarction: analysis of the TRIUMPH prospective cohort study.

Arnold SV, Spertus JA, Lipska KJ, Tang F, Goyal A, McGuire DK, Cresci S, Maddox TM, Kosiborod M.

Eur J Prev Cardiol. 2015 Jun;22(6):779-87. doi: 10.1177/2047487314533622. Epub 2014 Apr 16.

20.

CHRNA5 variant predicts smoking cessation in patients with acute myocardial infarction.

Chen LS, Bach RG, Lenzini PA, Spertus JA, Bierut LJ, Cresci S.

Nicotine Tob Res. 2014 Sep;16(9):1224-31. doi: 10.1093/ntr/ntu059. Epub 2014 Apr 11.

21.

Insulin resistance is associated with significant clinical atherosclerosis in nondiabetic patients with acute myocardial infarction.

Karrowni W, Li Y, Jones PG, Cresci S, Abdallah MS, Lanfear DE, Maddox TM, McGuire DK, Spertus JA, Horwitz PA.

Arterioscler Thromb Vasc Biol. 2013 Sep;33(9):2245-51. doi: 10.1161/ATVBAHA.113.301585. Epub 2013 Jul 18.

22.

Detection of rare genomic variants from pooled sequencing using SPLINTER.

Vallania F, Ramos E, Cresci S, Mitra RD, Druley TE.

J Vis Exp. 2012 Jun 23;(64). pii: 3943. doi: 10.3791/3943.

23.

Adrenergic-pathway gene variants influence beta-blocker-related outcomes after acute coronary syndrome in a race-specific manner.

Cresci S, Dorn GW 2nd, Jones PG, Beitelshees AL, Li AY, Lenzini PA, Province MA, Spertus JA, Lanfear DE.

J Am Coll Cardiol. 2012 Sep 4;60(10):898-907. doi: 10.1016/j.jacc.2012.02.051. Epub 2012 Jun 13.

24.

ADRB1 variants in atrial fibrillation: small steps and giant leaps toward personalized therapy in cardiovascular disease.

Cresci S.

J Am Coll Cardiol. 2012 Jan 3;59(1):57-9. doi: 10.1016/j.jacc.2011.09.041. No abstract available.

25.

Investigation of 95 variants identified in a genome-wide study for association with mortality after acute coronary syndrome.

Morgan TM, House JA, Cresci S, Jones P, Allayee H, Hazen SL, Patel Y, Patel RS, Eapen DJ, Waddy SP, Quyyumi AA, Kleber ME, März W, Winkelmann BR, Boehm BO, Krumholz HM, Spertus JA.

BMC Med Genet. 2011 Sep 29;12:127. doi: 10.1186/1471-2350-12-127.

26.

Peroxisome proliferator-activated receptor pathway gene polymorphism associated with extent of coronary artery disease in patients with type 2 diabetes in the bypass angioplasty revascularization investigation 2 diabetes trial.

Cresci S, Wu J, Province MA, Spertus JA, Steffes M, McGill JB, Alderman EL, Brooks MM, Kelsey SF, Frye RL, Bach RG; BARI 2D Study Group.

Circulation. 2011 Sep 27;124(13):1426-34. doi: 10.1161/CIRCULATIONAHA.111.029173. Epub 2011 Sep 12.

27.

Factors influencing patient willingness to participate in genetic research after a myocardial infarction.

Lanfear DE, Jones PG, Cresci S, Tang F, Rathore SS, Spertus JA.

Genome Med. 2011 Jun 15;3(6):39. doi: 10.1186/gm255.

28.

Chromosome 9p21 haplotypes and prognosis in white and black patients with coronary artery disease.

Gong Y, Beitelshees AL, Cooper-DeHoff RM, Lobmeyer MT, Langaee TY, Wu J, Cresci S, Province MA, Spertus JA, Pepine CJ, Johnson JA.

Circ Cardiovasc Genet. 2011 Apr;4(2):169-78. doi: 10.1161/CIRCGENETICS.110.959296. Epub 2011 Mar 3.

29.

Aromatase gene polymorphisms are associated with survival among patients with cardiovascular disease in a sex-specific manner.

Beitelshees AL, Johnson JA, Hames ML, Gong Y, Cooper-Dehoff RM, Wu J, Cresci S, Ma CX, Pepine CJ, Province MA, Spertus JA, McLeod HL.

PLoS One. 2010 Dec 10;5(12):e15180. doi: 10.1371/journal.pone.0015180.

30.

A PPARα promoter variant impairs ERR-dependent transactivation and decreases mortality after acute coronary ischemia in patients with diabetes.

Cresci S, Huss JM, Beitelshees AL, Jones PG, Minton MR, Dorn GW, Kelly DP, Spertus JA, McLeod HL.

PLoS One. 2010 Sep 3;5(9):e12584. doi: 10.1371/journal.pone.0012584.

31.

Echocardiographic tissue characterization demonstrates differences in the left and right sides of the ventricular septum.

Holland MR, Gibson AA, Bauer AQ, Peterson LR, Schaffer JE, Bach RG, Cresci S, Miller JG.

Ultrasound Med Biol. 2010 Oct;36(10):1653-61. doi: 10.1016/j.ultrasmedbio.2010.07.007.

32.

Interaction between the UCP2 -866 G>A polymorphism, diabetes, and beta-blocker use among patients with acute coronary syndromes.

Beitelshees AL, Finck BN, Leone TC, Cresci S, Wu J, Province MA, Fabbrini E, Kirk E, Zineh I, Klein S, Spertus JA, Kelly DP.

Pharmacogenet Genomics. 2010 Apr;20(4):231-8. doi: 10.1097/FPC.0b013e3283377abc. Erratum in: Pharmacogenet Genomics. 2012 May;22(5):396.

33.

Common variants in HSPB7 and FRMD4B associated with advanced heart failure.

Cappola TP, Li M, He J, Ky B, Gilmore J, Qu L, Keating B, Reilly M, Kim CE, Glessner J, Frackelton E, Hakonarson H, Syed F, Hindes A, Matkovich SJ, Cresci S, Dorn GW 2nd.

Circ Cardiovasc Genet. 2010 Apr;3(2):147-54. doi: 10.1161/CIRCGENETICS.109.898395. Epub 2010 Feb 2.

34.

Clinical and genetic modifiers of long-term survival in heart failure.

Cresci S, Kelly RJ, Cappola TP, Diwan A, Dries D, Kardia SL, Dorn GW 2nd.

J Am Coll Cardiol. 2009 Jul 28;54(5):432-44. doi: 10.1016/j.jacc.2009.05.009.

35.

Genome-wide association studies of coronary artery disease and heart failure: where are we going?

Dorn GW, Cresci S.

Pharmacogenomics. 2009 Feb;10(2):213-23. doi: 10.2217/14622416.10.2.213.

36.

PGC-1alpha and ERRalpha target gene downregulation is a signature of the failing human heart.

Sihag S, Cresci S, Li AY, Sucharov CC, Lehman JJ.

J Mol Cell Cardiol. 2009 Feb;46(2):201-12. doi: 10.1016/j.yjmcc.2008.10.025. Epub 2008 Nov 11.

37.

PPAR transcriptional activator complex polymorphisms and the promise of individualized therapy for heart failure.

Mistry NF, Cresci S.

Heart Fail Rev. 2010 May;15(3):197-207. doi: 10.1007/s10741-008-9114-x. Epub 2008 Nov 8. Review.

38.

Interaction between PPARA genotype and beta-blocker treatment influences clinical outcomes following acute coronary syndromes.

Cresci S, Jones PG, Sucharov CC, Marsh S, Lanfear DE, Garsa A, Courtois M, Weinheimer CJ, Wu J, Province MA, Kelly DP, McLeod HL, Spertus JA.

Pharmacogenomics. 2008 Oct;9(10):1403-17. doi: 10.2217/14622416.9.10.1403.

39.

Epithelial neutrophil-activating peptide (ENA-78), acute coronary syndrome prognosis, and modulatory effect of statins.

Zineh I, Beitelshees AL, Welder GJ, Hou W, Chegini N, Wu J, Cresci S, Province MA, Spertus JA.

PLoS One. 2008 Sep 3;3(9):e3117. doi: 10.1371/journal.pone.0003117.

40.

The mechanistic imperative for pharmacogenomics.

Dorn GW 2nd, Cresci S.

Pharmacogenomics. 2008 Jul;9(7):801-3. doi: 10.2217/14622416.9.7.801. No abstract available.

41.

A GRK5 polymorphism that inhibits beta-adrenergic receptor signaling is protective in heart failure.

Liggett SB, Cresci S, Kelly RJ, Syed FM, Matkovich SJ, Hahn HS, Diwan A, Martini JS, Sparks L, Parekh RR, Spertus JA, Koch WJ, Kardia SL, Dorn GW 2nd.

Nat Med. 2008 May;14(5):510-7. doi: 10.1038/nm1750. Epub 2008 Apr 20.

42.

PPAR Genomics and Pharmacogenomics: Implications for Cardiovascular Disease.

Cresci S.

PPAR Res. 2008;2008:374549. doi: 10.1155/2008/374549.

43.

From SNPs to functional studies in cardiovascular pharmacogenomics.

Cresci S.

Methods Mol Biol. 2008;448:379-93. doi: 10.1007/978-1-59745-205-2_12. Review.

PMID:
18370238
44.

Pharmacogenetics of the PPAR genes and cardiovascular disease.

Cresci S.

Pharmacogenomics. 2007 Nov;8(11):1581-95. Review.

PMID:
18034623
45.

Connexin37 (GJA4) genotype predicts survival after an acute coronary syndrome.

Lanfear DE, Jones PG, Marsh S, Cresci S, Spertus JA, McLeod HL.

Am Heart J. 2007 Sep;154(3):561-6.

PMID:
17719307
46.

Image-guided cardiovascular functional genomics: finding the needle in the haystack.

Cresci S, Gropler RJ.

J Nucl Cardiol. 2007 May-Jun;14(3):275-6. No abstract available.

47.

The PPAR genes, cardiovascular disease and the emergence of PPAR pharmacogenetics.

Cresci S.

Expert Opin Pharmacother. 2005 Dec;6(15):2577-91. Review.

PMID:
16316298
48.

Beta2-adrenergic receptor genotype and survival among patients receiving beta-blocker therapy after an acute coronary syndrome.

Lanfear DE, Jones PG, Marsh S, Cresci S, McLeod HL, Spertus JA.

JAMA. 2005 Sep 28;294(12):1526-33.

PMID:
16189366
49.

Genotypes associated with myocardial infarction risk are more common in African Americans than in European Americans.

Lanfear DE, Marsh S, Cresci S, Shannon WD, Spertus JA, McLeod HL.

J Am Coll Cardiol. 2004 Jul 7;44(1):165-7.

50.

Frequency of compound genotypes associated with beta-blocker efficacy in congestive heart failure.

Lanfear DE, Marsh S, Cresci S, Spertus JA, McLeod HL.

Pharmacogenomics. 2004 Jul;5(5):553-8.

PMID:
15212591

Supplemental Content

Loading ...
Support Center